We have reached a significant milestone in the development of Cardiawave with the opening of the clinical site Kerckhoff-Klinik, located in Bad Nauheim (Germany), in the beginning of May, for our on-going European “Valvosoft® Pivotal Study”! 
This achievement brings us one step closer to bringing our innovative treatment of calcific aortic stenosis to patients in need around the world, and the opening of the site Kerckhoff-Klinik will accelerate our progress towards bringing our non-invasive ultrasound therapy (NIUT) device to market.
We would like to express our gratitude to Prof. Christian Hamm and our partners at Kerckhoff-Klinik, as well as the patients and medical professionals who will participate in this clinical study. 
We will keep you updated on the progress of the clinical investigation, and we remain committed to our mission of transforming healthcare through innovation. Thank you for your support!
Kerckhoff-Klinik GmbH Physics for Medicine Paris #InstitutLangevin CNRS – Centre national de la recherche scientifique, ESPCI Paris – PSL, Inserm RHU STOP AS #HeartValveDisease #FocusedUltrasound #MedTech #AorticStenosis #HeartValveDisease #Medtech #FrenchCare #Health20